nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolcapone—CYP2C9—Capecitabine—kidney cancer	0.0816	0.458	CbGbCtD
Tolcapone—CYP2C9—Paclitaxel—kidney cancer	0.0511	0.287	CbGbCtD
Tolcapone—CYP2C9—Sorafenib—kidney cancer	0.0454	0.255	CbGbCtD
Tolcapone—COMT—Neurotransmitter Clearance In The Synaptic Cleft—ACHE—kidney cancer	0.00744	0.14	CbGpPWpGaD
Tolcapone—COMT—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—kidney cancer	0.00648	0.122	CbGpPWpGaD
Tolcapone—COMT—Biogenic Amine Synthesis—ACHE—kidney cancer	0.0045	0.0847	CbGpPWpGaD
Tolcapone—CYP2C9—urine—kidney cancer	0.00405	0.27	CbGeAlD
Tolcapone—Tolmetin—PTGS1—kidney cancer	0.00278	0.636	CrCbGaD
Tolcapone—COMT—Estrogen metabolism—GSTM1—kidney cancer	0.00248	0.0466	CbGpPWpGaD
Tolcapone—COMT—Estrogen metabolism—CYP1A1—kidney cancer	0.00235	0.0442	CbGpPWpGaD
Tolcapone—COMT—nephron tubule—kidney cancer	0.00207	0.138	CbGeAlD
Tolcapone—COMT—Biological oxidations—ACY1—kidney cancer	0.00199	0.0373	CbGpPWpGaD
Tolcapone—COMT—renal system—kidney cancer	0.00188	0.126	CbGeAlD
Tolcapone—COMT—kidney—kidney cancer	0.00182	0.122	CbGeAlD
Tolcapone—COMT—cortex of kidney—kidney cancer	0.00177	0.118	CbGeAlD
Tolcapone—COMT—gonad—kidney cancer	0.00169	0.113	CbGeAlD
Tolcapone—COMT—cardiac atrium—kidney cancer	0.00169	0.113	CbGeAlD
Tolcapone—Tolmetin—PTGS2—kidney cancer	0.00159	0.364	CrCbGaD
Tolcapone—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—kidney cancer	0.00147	0.0277	CbGpPWpGaD
Tolcapone—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—kidney cancer	0.00115	0.0217	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—GSTT1—kidney cancer	0.00109	0.0206	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—ALDH1A1—kidney cancer	0.00109	0.0205	CbGpPWpGaD
Tolcapone—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—kidney cancer	0.00105	0.0197	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—GSTP1—kidney cancer	0.000758	0.0142	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—GSTM1—kidney cancer	0.000696	0.0131	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—GSTT1—kidney cancer	0.00064	0.012	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—PTGS1—kidney cancer	0.000599	0.0113	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—KCNMA1—kidney cancer	0.000587	0.011	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—ACHE—kidney cancer	0.000567	0.0107	CbGpPWpGaD
Tolcapone—CYP2C9—Xenobiotics—CYP1A1—kidney cancer	0.000554	0.0104	CbGpPWpGaD
Tolcapone—CYP2C9—Tamoxifen metabolism—CYP1A1—kidney cancer	0.000533	0.01	CbGpPWpGaD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000526	0.00989	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—ACY1—kidney cancer	0.00051	0.00959	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—BCHE—kidney cancer	0.000494	0.00929	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—GSTP1—kidney cancer	0.000443	0.00834	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—GSTP1—kidney cancer	0.000437	0.00822	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—ACHE—kidney cancer	0.000434	0.00817	CbGpPWpGaD
Tolcapone—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.000414	0.00778	CbGpPWpGaD
Tolcapone—CYP2C9—Arachidonic acid metabolism—PTGS1—kidney cancer	0.000413	0.00777	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—GSTM1—kidney cancer	0.000407	0.00766	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—GSTM1—kidney cancer	0.000402	0.00755	CbGpPWpGaD
Tolcapone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000394	0.00741	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—CYP1A1—kidney cancer	0.000386	0.00726	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—CYP1A1—kidney cancer	0.000381	0.00716	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—BCHE—kidney cancer	0.000378	0.00711	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ACY1—kidney cancer	0.00034	0.00639	CbGpPWpGaD
Tolcapone—Chest pain—Paclitaxel—kidney cancer	0.000297	0.000397	CcSEcCtD
Tolcapone—Myalgia—Paclitaxel—kidney cancer	0.000297	0.000397	CcSEcCtD
Tolcapone—Mediastinal disorder—Capecitabine—kidney cancer	0.000297	0.000396	CcSEcCtD
Tolcapone—Anxiety—Paclitaxel—kidney cancer	0.000296	0.000395	CcSEcCtD
Tolcapone—Face oedema—Doxorubicin—kidney cancer	0.000296	0.000395	CcSEcCtD
Tolcapone—Decreased appetite—Gemcitabine—kidney cancer	0.000296	0.000395	CcSEcCtD
Tolcapone—Hypersensitivity—Dactinomycin—kidney cancer	0.000296	0.000395	CcSEcCtD
Tolcapone—Chills—Capecitabine—kidney cancer	0.000295	0.000394	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000295	0.000394	CcSEcCtD
Tolcapone—Arrhythmia—Capecitabine—kidney cancer	0.000294	0.000392	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000294	0.000392	CcSEcCtD
Tolcapone—Discomfort—Paclitaxel—kidney cancer	0.000294	0.000392	CcSEcCtD
Tolcapone—Fatigue—Gemcitabine—kidney cancer	0.000293	0.000392	CcSEcCtD
Tolcapone—Gastrointestinal pain—Vincristine—kidney cancer	0.000293	0.000391	CcSEcCtD
Tolcapone—Cardiac arrest—Doxorubicin—kidney cancer	0.000292	0.000389	CcSEcCtD
Tolcapone—Dizziness—Sorafenib—kidney cancer	0.000291	0.000389	CcSEcCtD
Tolcapone—Constipation—Gemcitabine—kidney cancer	0.000291	0.000388	CcSEcCtD
Tolcapone—Pain—Gemcitabine—kidney cancer	0.000291	0.000388	CcSEcCtD
Tolcapone—Nausea—Erlotinib—kidney cancer	0.000291	0.000388	CcSEcCtD
Tolcapone—Alopecia—Capecitabine—kidney cancer	0.000291	0.000388	CcSEcCtD
Tolcapone—Dry mouth—Paclitaxel—kidney cancer	0.000291	0.000388	CcSEcCtD
Tolcapone—Mood swings—Doxorubicin—kidney cancer	0.00029	0.000388	CcSEcCtD
Tolcapone—Diarrhoea—Sunitinib—kidney cancer	0.00029	0.000387	CcSEcCtD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.00029	0.00545	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PDHB—kidney cancer	0.000289	0.00543	CbGpPWpGaD
Tolcapone—Mental disorder—Capecitabine—kidney cancer	0.000288	0.000385	CcSEcCtD
Tolcapone—Asthenia—Dactinomycin—kidney cancer	0.000288	0.000384	CcSEcCtD
Tolcapone—COMT—Biological oxidations—POMC—kidney cancer	0.000288	0.00541	CbGpPWpGaD
Tolcapone—Confusional state—Paclitaxel—kidney cancer	0.000287	0.000383	CcSEcCtD
Tolcapone—Dehydration—Doxorubicin—kidney cancer	0.000285	0.000381	CcSEcCtD
Tolcapone—Oedema—Paclitaxel—kidney cancer	0.000285	0.00038	CcSEcCtD
Tolcapone—Body temperature increased—Vincristine—kidney cancer	0.000284	0.000378	CcSEcCtD
Tolcapone—Abdominal pain—Vincristine—kidney cancer	0.000284	0.000378	CcSEcCtD
Tolcapone—Infection—Paclitaxel—kidney cancer	0.000283	0.000378	CcSEcCtD
Tolcapone—Flatulence—Capecitabine—kidney cancer	0.000282	0.000377	CcSEcCtD
Tolcapone—Dysgeusia—Capecitabine—kidney cancer	0.000281	0.000374	CcSEcCtD
Tolcapone—Dizziness—Sunitinib—kidney cancer	0.00028	0.000374	CcSEcCtD
Tolcapone—Feeling abnormal—Gemcitabine—kidney cancer	0.00028	0.000374	CcSEcCtD
Tolcapone—Shock—Paclitaxel—kidney cancer	0.00028	0.000374	CcSEcCtD
Tolcapone—Vomiting—Sorafenib—kidney cancer	0.00028	0.000374	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—ALDH1A1—kidney cancer	0.000279	0.00525	CbGpPWpGaD
Tolcapone—Nervous system disorder—Paclitaxel—kidney cancer	0.000279	0.000373	CcSEcCtD
Tolcapone—Thrombocytopenia—Paclitaxel—kidney cancer	0.000279	0.000372	CcSEcCtD
Tolcapone—Tachycardia—Paclitaxel—kidney cancer	0.000278	0.000371	CcSEcCtD
Tolcapone—Rash—Sorafenib—kidney cancer	0.000278	0.000371	CcSEcCtD
Tolcapone—Dermatitis—Sorafenib—kidney cancer	0.000278	0.000371	CcSEcCtD
Tolcapone—Skin disorder—Paclitaxel—kidney cancer	0.000277	0.000369	CcSEcCtD
Tolcapone—Headache—Sorafenib—kidney cancer	0.000276	0.000368	CcSEcCtD
Tolcapone—Muscle spasms—Capecitabine—kidney cancer	0.000275	0.000368	CcSEcCtD
Tolcapone—Hyperhidrosis—Paclitaxel—kidney cancer	0.000275	0.000368	CcSEcCtD
Tolcapone—Diarrhoea—Dactinomycin—kidney cancer	0.000275	0.000367	CcSEcCtD
Tolcapone—COMT—Metabolism—CCBL1—kidney cancer	0.000272	0.00511	CbGpPWpGaD
Tolcapone—Anorexia—Paclitaxel—kidney cancer	0.000272	0.000362	CcSEcCtD
Tolcapone—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.00027	0.000361	CcSEcCtD
Tolcapone—Vision blurred—Capecitabine—kidney cancer	0.00027	0.00036	CcSEcCtD
Tolcapone—Vomiting—Sunitinib—kidney cancer	0.00027	0.00036	CcSEcCtD
Tolcapone—Body temperature increased—Gemcitabine—kidney cancer	0.000269	0.000359	CcSEcCtD
Tolcapone—Tremor—Capecitabine—kidney cancer	0.000268	0.000358	CcSEcCtD
Tolcapone—Rash—Sunitinib—kidney cancer	0.000267	0.000357	CcSEcCtD
Tolcapone—Dermatitis—Sunitinib—kidney cancer	0.000267	0.000357	CcSEcCtD
Tolcapone—CYP2C9—Arachidonic acid metabolism—CYP1A1—kidney cancer	0.000266	0.00501	CbGpPWpGaD
Tolcapone—Hypotension—Paclitaxel—kidney cancer	0.000266	0.000355	CcSEcCtD
Tolcapone—Ill-defined disorder—Capecitabine—kidney cancer	0.000266	0.000355	CcSEcCtD
Tolcapone—Headache—Sunitinib—kidney cancer	0.000266	0.000355	CcSEcCtD
Tolcapone—Dysphagia—Doxorubicin—kidney cancer	0.000265	0.000354	CcSEcCtD
Tolcapone—Asthma—Doxorubicin—kidney cancer	0.000265	0.000354	CcSEcCtD
Tolcapone—Influenza—Doxorubicin—kidney cancer	0.000265	0.000354	CcSEcCtD
Tolcapone—Anaemia—Capecitabine—kidney cancer	0.000265	0.000353	CcSEcCtD
Tolcapone—Hypersensitivity—Vincristine—kidney cancer	0.000264	0.000353	CcSEcCtD
Tolcapone—Nausea—Sorafenib—kidney cancer	0.000262	0.000349	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.00026	0.000346	CcSEcCtD
Tolcapone—Malaise—Capecitabine—kidney cancer	0.000258	0.000345	CcSEcCtD
Tolcapone—Angina pectoris—Doxorubicin—kidney cancer	0.000258	0.000345	CcSEcCtD
Tolcapone—Vertigo—Capecitabine—kidney cancer	0.000257	0.000343	CcSEcCtD
Tolcapone—Asthenia—Vincristine—kidney cancer	0.000257	0.000343	CcSEcCtD
Tolcapone—Syncope—Capecitabine—kidney cancer	0.000257	0.000343	CcSEcCtD
Tolcapone—Paraesthesia—Paclitaxel—kidney cancer	0.000256	0.000341	CcSEcCtD
Tolcapone—Vomiting—Dactinomycin—kidney cancer	0.000255	0.000341	CcSEcCtD
Tolcapone—Bronchitis—Doxorubicin—kidney cancer	0.000255	0.00034	CcSEcCtD
Tolcapone—Dyspnoea—Paclitaxel—kidney cancer	0.000254	0.000339	CcSEcCtD
Tolcapone—Somnolence—Paclitaxel—kidney cancer	0.000253	0.000338	CcSEcCtD
Tolcapone—Palpitations—Capecitabine—kidney cancer	0.000253	0.000338	CcSEcCtD
Tolcapone—Rash—Dactinomycin—kidney cancer	0.000253	0.000338	CcSEcCtD
Tolcapone—COMT—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000252	0.00474	CbGpPWpGaD
Tolcapone—Nausea—Sunitinib—kidney cancer	0.000252	0.000336	CcSEcCtD
Tolcapone—Loss of consciousness—Capecitabine—kidney cancer	0.000252	0.000336	CcSEcCtD
Tolcapone—Dyspepsia—Paclitaxel—kidney cancer	0.000251	0.000335	CcSEcCtD
Tolcapone—Cough—Capecitabine—kidney cancer	0.00025	0.000334	CcSEcCtD
Tolcapone—Dysuria—Doxorubicin—kidney cancer	0.000248	0.000331	CcSEcCtD
Tolcapone—Decreased appetite—Paclitaxel—kidney cancer	0.000248	0.000331	CcSEcCtD
Tolcapone—Hypertension—Capecitabine—kidney cancer	0.000247	0.00033	CcSEcCtD
Tolcapone—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000246	0.000329	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000246	0.000328	CcSEcCtD
Tolcapone—Fatigue—Paclitaxel—kidney cancer	0.000246	0.000328	CcSEcCtD
Tolcapone—Diarrhoea—Vincristine—kidney cancer	0.000245	0.000328	CcSEcCtD
Tolcapone—Pollakiuria—Doxorubicin—kidney cancer	0.000245	0.000327	CcSEcCtD
Tolcapone—Asthenia—Gemcitabine—kidney cancer	0.000244	0.000326	CcSEcCtD
Tolcapone—Myalgia—Capecitabine—kidney cancer	0.000244	0.000325	CcSEcCtD
Tolcapone—Chest pain—Capecitabine—kidney cancer	0.000244	0.000325	CcSEcCtD
Tolcapone—Arthralgia—Capecitabine—kidney cancer	0.000244	0.000325	CcSEcCtD
Tolcapone—Pain—Paclitaxel—kidney cancer	0.000244	0.000325	CcSEcCtD
Tolcapone—Constipation—Paclitaxel—kidney cancer	0.000244	0.000325	CcSEcCtD
Tolcapone—Anxiety—Capecitabine—kidney cancer	0.000243	0.000324	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000242	0.000323	CcSEcCtD
Tolcapone—Discomfort—Capecitabine—kidney cancer	0.000241	0.000322	CcSEcCtD
Tolcapone—Pruritus—Gemcitabine—kidney cancer	0.000241	0.000321	CcSEcCtD
Tolcapone—Weight decreased—Doxorubicin—kidney cancer	0.00024	0.00032	CcSEcCtD
Tolcapone—Dry mouth—Capecitabine—kidney cancer	0.000239	0.000318	CcSEcCtD
Tolcapone—Nausea—Dactinomycin—kidney cancer	0.000238	0.000318	CcSEcCtD
Tolcapone—Pneumonia—Doxorubicin—kidney cancer	0.000238	0.000317	CcSEcCtD
Tolcapone—Dizziness—Vincristine—kidney cancer	0.000237	0.000317	CcSEcCtD
Tolcapone—Infestation NOS—Doxorubicin—kidney cancer	0.000236	0.000315	CcSEcCtD
Tolcapone—Infestation—Doxorubicin—kidney cancer	0.000236	0.000315	CcSEcCtD
Tolcapone—Confusional state—Capecitabine—kidney cancer	0.000236	0.000315	CcSEcCtD
Tolcapone—COMT—Metabolism—GLIPR1—kidney cancer	0.000235	0.00443	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PPAT—kidney cancer	0.000235	0.00443	CbGpPWpGaD
Tolcapone—Feeling abnormal—Paclitaxel—kidney cancer	0.000235	0.000313	CcSEcCtD
Tolcapone—Oedema—Capecitabine—kidney cancer	0.000234	0.000312	CcSEcCtD
Tolcapone—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000233	0.000311	CcSEcCtD
Tolcapone—Diarrhoea—Gemcitabine—kidney cancer	0.000233	0.000311	CcSEcCtD
Tolcapone—Infection—Capecitabine—kidney cancer	0.000232	0.00031	CcSEcCtD
Tolcapone—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000232	0.000309	CcSEcCtD
Tolcapone—Stomatitis—Doxorubicin—kidney cancer	0.00023	0.000307	CcSEcCtD
Tolcapone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.00023	0.00433	CbGpPWpGaD
Tolcapone—Shock—Capecitabine—kidney cancer	0.00023	0.000307	CcSEcCtD
Tolcapone—Urinary tract infection—Doxorubicin—kidney cancer	0.00023	0.000307	CcSEcCtD
Tolcapone—Nervous system disorder—Capecitabine—kidney cancer	0.000229	0.000306	CcSEcCtD
Tolcapone—Thrombocytopenia—Capecitabine—kidney cancer	0.000229	0.000306	CcSEcCtD
Tolcapone—Tachycardia—Capecitabine—kidney cancer	0.000228	0.000305	CcSEcCtD
Tolcapone—Vomiting—Vincristine—kidney cancer	0.000228	0.000304	CcSEcCtD
Tolcapone—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000227	0.00427	CbGpPWpGaD
Tolcapone—Skin disorder—Capecitabine—kidney cancer	0.000227	0.000303	CcSEcCtD
Tolcapone—Sweating—Doxorubicin—kidney cancer	0.000227	0.000302	CcSEcCtD
Tolcapone—Urticaria—Paclitaxel—kidney cancer	0.000226	0.000302	CcSEcCtD
Tolcapone—Rash—Vincristine—kidney cancer	0.000226	0.000302	CcSEcCtD
Tolcapone—Hyperhidrosis—Capecitabine—kidney cancer	0.000226	0.000302	CcSEcCtD
Tolcapone—Dermatitis—Vincristine—kidney cancer	0.000226	0.000302	CcSEcCtD
Tolcapone—Haematuria—Doxorubicin—kidney cancer	0.000225	0.000301	CcSEcCtD
Tolcapone—Abdominal pain—Paclitaxel—kidney cancer	0.000225	0.000301	CcSEcCtD
Tolcapone—Body temperature increased—Paclitaxel—kidney cancer	0.000225	0.000301	CcSEcCtD
Tolcapone—Headache—Vincristine—kidney cancer	0.000225	0.0003	CcSEcCtD
Tolcapone—Epistaxis—Doxorubicin—kidney cancer	0.000223	0.000297	CcSEcCtD
Tolcapone—Anorexia—Capecitabine—kidney cancer	0.000223	0.000297	CcSEcCtD
Tolcapone—Sinusitis—Doxorubicin—kidney cancer	0.000222	0.000296	CcSEcCtD
Tolcapone—COMT—Metabolism—FH—kidney cancer	0.000219	0.00412	CbGpPWpGaD
Tolcapone—COMT—Metabolism—APRT—kidney cancer	0.000219	0.00412	CbGpPWpGaD
Tolcapone—Hypotension—Capecitabine—kidney cancer	0.000218	0.000292	CcSEcCtD
Tolcapone—Vomiting—Gemcitabine—kidney cancer	0.000216	0.000289	CcSEcCtD
Tolcapone—Bradycardia—Doxorubicin—kidney cancer	0.000216	0.000288	CcSEcCtD
Tolcapone—Rash—Gemcitabine—kidney cancer	0.000215	0.000286	CcSEcCtD
Tolcapone—Dermatitis—Gemcitabine—kidney cancer	0.000214	0.000286	CcSEcCtD
Tolcapone—Haemoglobin—Doxorubicin—kidney cancer	0.000213	0.000285	CcSEcCtD
Tolcapone—Headache—Gemcitabine—kidney cancer	0.000213	0.000284	CcSEcCtD
Tolcapone—Nausea—Vincristine—kidney cancer	0.000213	0.000284	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000213	0.000284	CcSEcCtD
Tolcapone—Rhinitis—Doxorubicin—kidney cancer	0.000213	0.000284	CcSEcCtD
Tolcapone—Haemorrhage—Doxorubicin—kidney cancer	0.000212	0.000283	CcSEcCtD
Tolcapone—Hypoaesthesia—Doxorubicin—kidney cancer	0.000211	0.000282	CcSEcCtD
Tolcapone—Pharyngitis—Doxorubicin—kidney cancer	0.000211	0.000281	CcSEcCtD
Tolcapone—COMT—Transmission across Chemical Synapses—RAF1—kidney cancer	0.00021	0.00396	CbGpPWpGaD
Tolcapone—Paraesthesia—Capecitabine—kidney cancer	0.00021	0.00028	CcSEcCtD
Tolcapone—Hypersensitivity—Paclitaxel—kidney cancer	0.00021	0.00028	CcSEcCtD
Tolcapone—Urinary tract disorder—Doxorubicin—kidney cancer	0.000209	0.00028	CcSEcCtD
Tolcapone—Oedema peripheral—Doxorubicin—kidney cancer	0.000209	0.000279	CcSEcCtD
Tolcapone—Dyspnoea—Capecitabine—kidney cancer	0.000208	0.000278	CcSEcCtD
Tolcapone—Urethral disorder—Doxorubicin—kidney cancer	0.000208	0.000278	CcSEcCtD
Tolcapone—COMT—Metabolism—GPC3—kidney cancer	0.000206	0.00387	CbGpPWpGaD
Tolcapone—Dyspepsia—Capecitabine—kidney cancer	0.000206	0.000275	CcSEcCtD
Tolcapone—Asthenia—Paclitaxel—kidney cancer	0.000204	0.000273	CcSEcCtD
Tolcapone—Decreased appetite—Capecitabine—kidney cancer	0.000203	0.000271	CcSEcCtD
Tolcapone—Nausea—Gemcitabine—kidney cancer	0.000202	0.00027	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000202	0.000269	CcSEcCtD
Tolcapone—Fatigue—Capecitabine—kidney cancer	0.000202	0.000269	CcSEcCtD
Tolcapone—Pruritus—Paclitaxel—kidney cancer	0.000202	0.000269	CcSEcCtD
Tolcapone—Erythema multiforme—Doxorubicin—kidney cancer	0.000201	0.000268	CcSEcCtD
Tolcapone—COMT—Metabolism—CA2—kidney cancer	0.0002	0.00376	CbGpPWpGaD
Tolcapone—Constipation—Capecitabine—kidney cancer	0.0002	0.000267	CcSEcCtD
Tolcapone—Pain—Capecitabine—kidney cancer	0.0002	0.000267	CcSEcCtD
Tolcapone—Tinnitus—Doxorubicin—kidney cancer	0.000198	0.000264	CcSEcCtD
Tolcapone—COMT—Metabolism—ALAD—kidney cancer	0.000195	0.00367	CbGpPWpGaD
Tolcapone—Diarrhoea—Paclitaxel—kidney cancer	0.000195	0.00026	CcSEcCtD
Tolcapone—COMT—Neuronal System—BRAF—kidney cancer	0.000193	0.00363	CbGpPWpGaD
Tolcapone—Feeling abnormal—Capecitabine—kidney cancer	0.000193	0.000257	CcSEcCtD
Tolcapone—Angiopathy—Doxorubicin—kidney cancer	0.000192	0.000257	CcSEcCtD
Tolcapone—Gastrointestinal pain—Capecitabine—kidney cancer	0.000191	0.000255	CcSEcCtD
Tolcapone—Mediastinal disorder—Doxorubicin—kidney cancer	0.000191	0.000255	CcSEcCtD
Tolcapone—COMT—Metabolism—ST3GAL2—kidney cancer	0.00019	0.00358	CbGpPWpGaD
Tolcapone—Chills—Doxorubicin—kidney cancer	0.00019	0.000254	CcSEcCtD
Tolcapone—Arrhythmia—Doxorubicin—kidney cancer	0.000189	0.000253	CcSEcCtD
Tolcapone—Dizziness—Paclitaxel—kidney cancer	0.000188	0.000251	CcSEcCtD
Tolcapone—Alopecia—Doxorubicin—kidney cancer	0.000187	0.00025	CcSEcCtD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000187	0.00351	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ALDH1A1—kidney cancer	0.000186	0.0035	CbGpPWpGaD
Tolcapone—Mental disorder—Doxorubicin—kidney cancer	0.000186	0.000248	CcSEcCtD
Tolcapone—Urticaria—Capecitabine—kidney cancer	0.000186	0.000248	CcSEcCtD
Tolcapone—Abdominal pain—Capecitabine—kidney cancer	0.000185	0.000247	CcSEcCtD
Tolcapone—Body temperature increased—Capecitabine—kidney cancer	0.000185	0.000247	CcSEcCtD
Tolcapone—Flatulence—Doxorubicin—kidney cancer	0.000182	0.000243	CcSEcCtD
Tolcapone—Tension—Doxorubicin—kidney cancer	0.000181	0.000242	CcSEcCtD
Tolcapone—Vomiting—Paclitaxel—kidney cancer	0.000181	0.000242	CcSEcCtD
Tolcapone—Dysgeusia—Doxorubicin—kidney cancer	0.000181	0.000241	CcSEcCtD
Tolcapone—Rash—Paclitaxel—kidney cancer	0.00018	0.00024	CcSEcCtD
Tolcapone—Dermatitis—Paclitaxel—kidney cancer	0.000179	0.00024	CcSEcCtD
Tolcapone—Nervousness—Doxorubicin—kidney cancer	0.000179	0.000239	CcSEcCtD
Tolcapone—Headache—Paclitaxel—kidney cancer	0.000178	0.000238	CcSEcCtD
Tolcapone—COMT—Metabolism—PGK1—kidney cancer	0.000178	0.00336	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SLC5A3—kidney cancer	0.000178	0.00336	CbGpPWpGaD
Tolcapone—Muscle spasms—Doxorubicin—kidney cancer	0.000178	0.000237	CcSEcCtD
Tolcapone—COMT—Metabolism—LDHB—kidney cancer	0.000175	0.00329	CbGpPWpGaD
Tolcapone—Vision blurred—Doxorubicin—kidney cancer	0.000174	0.000232	CcSEcCtD
Tolcapone—Hypersensitivity—Capecitabine—kidney cancer	0.000172	0.00023	CcSEcCtD
Tolcapone—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000172	0.00323	CbGpPWpGaD
Tolcapone—Ill-defined disorder—Doxorubicin—kidney cancer	0.000171	0.000229	CcSEcCtD
Tolcapone—Anaemia—Doxorubicin—kidney cancer	0.000171	0.000228	CcSEcCtD
Tolcapone—Agitation—Doxorubicin—kidney cancer	0.00017	0.000226	CcSEcCtD
Tolcapone—Nausea—Paclitaxel—kidney cancer	0.000169	0.000226	CcSEcCtD
Tolcapone—Asthenia—Capecitabine—kidney cancer	0.000168	0.000224	CcSEcCtD
Tolcapone—Malaise—Doxorubicin—kidney cancer	0.000167	0.000222	CcSEcCtD
Tolcapone—Vertigo—Doxorubicin—kidney cancer	0.000166	0.000221	CcSEcCtD
Tolcapone—Syncope—Doxorubicin—kidney cancer	0.000166	0.000221	CcSEcCtD
Tolcapone—Pruritus—Capecitabine—kidney cancer	0.000165	0.000221	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—GSTT1—kidney cancer	0.000164	0.00309	CbGpPWpGaD
Tolcapone—Palpitations—Doxorubicin—kidney cancer	0.000163	0.000218	CcSEcCtD
Tolcapone—Loss of consciousness—Doxorubicin—kidney cancer	0.000162	0.000217	CcSEcCtD
Tolcapone—COMT—Neuronal System—RAF1—kidney cancer	0.000161	0.00303	CbGpPWpGaD
Tolcapone—Cough—Doxorubicin—kidney cancer	0.000161	0.000215	CcSEcCtD
Tolcapone—Diarrhoea—Capecitabine—kidney cancer	0.00016	0.000213	CcSEcCtD
Tolcapone—Hypertension—Doxorubicin—kidney cancer	0.000159	0.000213	CcSEcCtD
Tolcapone—CYP2C9—Arachidonic acid metabolism—PTGS2—kidney cancer	0.000158	0.00298	CbGpPWpGaD
Tolcapone—Chest pain—Doxorubicin—kidney cancer	0.000157	0.00021	CcSEcCtD
Tolcapone—Arthralgia—Doxorubicin—kidney cancer	0.000157	0.00021	CcSEcCtD
Tolcapone—Myalgia—Doxorubicin—kidney cancer	0.000157	0.00021	CcSEcCtD
Tolcapone—Anxiety—Doxorubicin—kidney cancer	0.000157	0.000209	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000156	0.000208	CcSEcCtD
Tolcapone—Discomfort—Doxorubicin—kidney cancer	0.000155	0.000207	CcSEcCtD
Tolcapone—Dizziness—Capecitabine—kidney cancer	0.000155	0.000206	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—PTGS1—kidney cancer	0.000154	0.00289	CbGpPWpGaD
Tolcapone—Dry mouth—Doxorubicin—kidney cancer	0.000154	0.000205	CcSEcCtD
Tolcapone—Confusional state—Doxorubicin—kidney cancer	0.000152	0.000203	CcSEcCtD
Tolcapone—COMT—Metabolism—CA9—kidney cancer	0.000152	0.00285	CbGpPWpGaD
Tolcapone—Oedema—Doxorubicin—kidney cancer	0.000151	0.000201	CcSEcCtD
Tolcapone—Infection—Doxorubicin—kidney cancer	0.00015	0.0002	CcSEcCtD
Tolcapone—Vomiting—Capecitabine—kidney cancer	0.000149	0.000198	CcSEcCtD
Tolcapone—Shock—Doxorubicin—kidney cancer	0.000148	0.000198	CcSEcCtD
Tolcapone—Nervous system disorder—Doxorubicin—kidney cancer	0.000148	0.000197	CcSEcCtD
Tolcapone—Thrombocytopenia—Doxorubicin—kidney cancer	0.000148	0.000197	CcSEcCtD
Tolcapone—Rash—Capecitabine—kidney cancer	0.000147	0.000197	CcSEcCtD
Tolcapone—Dermatitis—Capecitabine—kidney cancer	0.000147	0.000197	CcSEcCtD
Tolcapone—Tachycardia—Doxorubicin—kidney cancer	0.000147	0.000196	CcSEcCtD
Tolcapone—Headache—Capecitabine—kidney cancer	0.000146	0.000195	CcSEcCtD
Tolcapone—Skin disorder—Doxorubicin—kidney cancer	0.000146	0.000195	CcSEcCtD
Tolcapone—Hyperhidrosis—Doxorubicin—kidney cancer	0.000146	0.000194	CcSEcCtD
Tolcapone—COMT—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000144	0.00271	CbGpPWpGaD
Tolcapone—Anorexia—Doxorubicin—kidney cancer	0.000144	0.000192	CcSEcCtD
Tolcapone—Hypotension—Doxorubicin—kidney cancer	0.000141	0.000188	CcSEcCtD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000139	0.00262	CbGpPWpGaD
Tolcapone—Nausea—Capecitabine—kidney cancer	0.000139	0.000185	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000137	0.000183	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000136	0.00255	CbGpPWpGaD
Tolcapone—Paraesthesia—Doxorubicin—kidney cancer	0.000135	0.000181	CcSEcCtD
Tolcapone—Dyspnoea—Doxorubicin—kidney cancer	0.000134	0.000179	CcSEcCtD
Tolcapone—Somnolence—Doxorubicin—kidney cancer	0.000134	0.000179	CcSEcCtD
Tolcapone—Dyspepsia—Doxorubicin—kidney cancer	0.000133	0.000177	CcSEcCtD
Tolcapone—Decreased appetite—Doxorubicin—kidney cancer	0.000131	0.000175	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.00013	0.000174	CcSEcCtD
Tolcapone—Fatigue—Doxorubicin—kidney cancer	0.00013	0.000173	CcSEcCtD
Tolcapone—COMT—Metabolism—CRABP1—kidney cancer	0.000129	0.00243	CbGpPWpGaD
Tolcapone—Constipation—Doxorubicin—kidney cancer	0.000129	0.000172	CcSEcCtD
Tolcapone—Pain—Doxorubicin—kidney cancer	0.000129	0.000172	CcSEcCtD
Tolcapone—Feeling abnormal—Doxorubicin—kidney cancer	0.000124	0.000166	CcSEcCtD
Tolcapone—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000123	0.000164	CcSEcCtD
Tolcapone—COMT—Metabolism—ITPR2—kidney cancer	0.00012	0.00226	CbGpPWpGaD
Tolcapone—Urticaria—Doxorubicin—kidney cancer	0.00012	0.00016	CcSEcCtD
Tolcapone—Body temperature increased—Doxorubicin—kidney cancer	0.000119	0.000159	CcSEcCtD
Tolcapone—Abdominal pain—Doxorubicin—kidney cancer	0.000119	0.000159	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—GSTP1—kidney cancer	0.000114	0.00214	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	0.000112	0.00211	CbGpPWpGaD
Tolcapone—Hypersensitivity—Doxorubicin—kidney cancer	0.000111	0.000148	CcSEcCtD
Tolcapone—COMT—Neuronal System—MAPK1—kidney cancer	0.000111	0.00208	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GSTT1—kidney cancer	0.000109	0.00206	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ACHE—kidney cancer	0.000109	0.00206	CbGpPWpGaD
Tolcapone—Asthenia—Doxorubicin—kidney cancer	0.000108	0.000144	CcSEcCtD
Tolcapone—Pruritus—Doxorubicin—kidney cancer	0.000107	0.000142	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—GSTM1—kidney cancer	0.000105	0.00197	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SCARB1—kidney cancer	0.000104	0.00195	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	0.000103	0.00194	CbGpPWpGaD
Tolcapone—Diarrhoea—Doxorubicin—kidney cancer	0.000103	0.000138	CcSEcCtD
Tolcapone—COMT—Metabolism—PTGS1—kidney cancer	0.000102	0.00193	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PSMD7—kidney cancer	0.000101	0.00189	CbGpPWpGaD
Tolcapone—Dizziness—Doxorubicin—kidney cancer	9.97e-05	0.000133	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	9.91e-05	0.00186	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	9.78e-05	0.00184	CbGpPWpGaD
Tolcapone—Vomiting—Doxorubicin—kidney cancer	9.58e-05	0.000128	CcSEcCtD
Tolcapone—COMT—Metabolism—BCHE—kidney cancer	9.53e-05	0.00179	CbGpPWpGaD
Tolcapone—Rash—Doxorubicin—kidney cancer	9.5e-05	0.000127	CcSEcCtD
Tolcapone—Dermatitis—Doxorubicin—kidney cancer	9.49e-05	0.000127	CcSEcCtD
Tolcapone—Headache—Doxorubicin—kidney cancer	9.44e-05	0.000126	CcSEcCtD
Tolcapone—COMT—Metabolism—SLC5A5—kidney cancer	9.41e-05	0.00177	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SLC2A1—kidney cancer	9.09e-05	0.00171	CbGpPWpGaD
Tolcapone—Nausea—Doxorubicin—kidney cancer	8.95e-05	0.000119	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—ACY1—kidney cancer	8.72e-05	0.00164	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GSTP1—kidney cancer	7.58e-05	0.00143	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	7.44e-05	0.0014	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PDHB—kidney cancer	7.42e-05	0.00139	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—POMC—kidney cancer	7.39e-05	0.00139	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ABCB1—kidney cancer	7.18e-05	0.00135	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CCBL1—kidney cancer	6.97e-05	0.00131	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GSTM1—kidney cancer	6.97e-05	0.00131	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYP1A1—kidney cancer	6.6e-05	0.00124	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	6.3e-05	0.00119	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GLIPR1—kidney cancer	6.04e-05	0.00114	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PPAT—kidney cancer	6.04e-05	0.00114	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	5.97e-05	0.00112	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	5.91e-05	0.00111	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—APRT—kidney cancer	5.62e-05	0.00106	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—FH—kidney cancer	5.62e-05	0.00106	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	5.49e-05	0.00103	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GPC3—kidney cancer	5.28e-05	0.000993	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CA2—kidney cancer	5.14e-05	0.000966	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ALAD—kidney cancer	5.01e-05	0.000942	CbGpPWpGaD
Tolcapone—COMT—Metabolism—POMC—kidney cancer	4.92e-05	0.000926	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ST3GAL2—kidney cancer	4.89e-05	0.000919	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ALDH1A1—kidney cancer	4.78e-05	0.000898	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PGK1—kidney cancer	4.58e-05	0.000861	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SLC5A3—kidney cancer	4.58e-05	0.000861	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—LDHB—kidney cancer	4.49e-05	0.000845	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PTGS2—kidney cancer	3.93e-05	0.000738	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CA9—kidney cancer	3.9e-05	0.000732	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.81e-05	0.000716	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PTEN—kidney cancer	3.43e-05	0.000644	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CRABP1—kidney cancer	3.31e-05	0.000623	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ITPR2—kidney cancer	3.08e-05	0.000579	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.84e-05	0.000534	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ACHE—kidney cancer	2.81e-05	0.000528	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTT1—kidney cancer	2.81e-05	0.000528	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SCARB1—kidney cancer	2.66e-05	0.0005	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PTGS1—kidney cancer	2.63e-05	0.000495	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PSMD7—kidney cancer	2.58e-05	0.000485	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—BCHE—kidney cancer	2.45e-05	0.00046	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PIK3CA—kidney cancer	2.42e-05	0.000454	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SLC5A5—kidney cancer	2.42e-05	0.000454	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SLC2A1—kidney cancer	2.33e-05	0.000439	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.26e-05	0.000426	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.97e-05	0.000371	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTP1—kidney cancer	1.95e-05	0.000366	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ABCB1—kidney cancer	1.84e-05	0.000346	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTM1—kidney cancer	1.79e-05	0.000336	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP1A1—kidney cancer	1.7e-05	0.000319	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.39e-05	0.000262	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—POMC—kidney cancer	1.26e-05	0.000238	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PTGS2—kidney cancer	1.01e-05	0.00019	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PTEN—kidney cancer	8.79e-06	0.000165	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIK3CA—kidney cancer	6.2e-06	0.000117	CbGpPWpGaD
